Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand
- PMID: 12757237
Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand
Abstract
Hepatitis C virus (HCV) is an infectious agent that has the potential to cause chronic liver disease, cirrhosis and hepatocellular carcinoma. We determined the prevalence and genotypes of HCV infection among groups of drug addicts: intravenous drug users (n = 134), methamphetamine users (n = 100), inhaled-drugs users (n = 19) and alcoholics (n = 50); a group of blood donors acted as a control. The control group consisted of 179 randomly-selected anti-HCV positive samples: these were subjected to HCV RNA screening and genotyping. The anti-HCV test was performed by ELISA: HCV RNA screening was by nested RT-PCR that employed primers from the 5' noncoding region. The genotype assay was based upon analysis of the 5' NCR amplified sequences and RFLP. Hepatitis C virus was highly prevalent among all groups of drug addicts (12-70%). In 2000. among the new blood donors (n = 66,340) at the National Blood Center, Thai Red Cross, anti-HCV prevalence amounted to 0.98%. The HCV genotype distribution showed that the most prevalent genotype was 3a, followed by 1b and 6a. Our data demonstrated the very high prevalence of HCV infection in IVDUs, a finding that is consistent with the blood-borne nature of the virus. In order to curb HCV infection, a determined effort to educate both the general population and high-risk groups is required; such a program of education would address both general and particular methods of transmission, especially the use of non-sterile needles etc.
Similar articles
-
Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.Jpn J Infect Dis. 1999 Jun;52(3):121-3. Jpn J Infect Dis. 1999. PMID: 10507992
-
An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.Saudi Med J. 2007 Mar;28(3):390-5. Saudi Med J. 2007. PMID: 17334466
-
High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups.Infect Genet Evol. 2006 May;6(3):198-204. doi: 10.1016/j.meegid.2005.04.001. Epub 2005 Jun 28. Infect Genet Evol. 2006. PMID: 15990361
-
Chronic hepatitis C.Dis Mon. 1994 Mar;40(3):117-96. Dis Mon. 1994. PMID: 7513276 Review.
-
Hepatitis C virus : prevalence in Lebanese blood donors and brief overview of the disease.J Med Liban. 1995;43(1):11-6. J Med Liban. 1995. PMID: 8676356 Review.
Cited by
-
HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.Vaccine. 2011 Feb 24;29(10):1991-6. doi: 10.1016/j.vaccine.2010.12.043. Epub 2011 Jan 15. Vaccine. 2011. PMID: 21241735 Free PMC article.
-
Molecular epidemiology of hepatitis C virus in Cambodia during 2016-2017.Sci Rep. 2019 May 13;9(1):7314. doi: 10.1038/s41598-019-43785-4. Sci Rep. 2019. PMID: 31086236 Free PMC article.
-
The Dual Burden of Hepatitis B and C Among Drug Users in Asia: The First Systematic Review and Meta-Analysis.Pathogens. 2025 Apr 7;14(4):360. doi: 10.3390/pathogens14040360. Pathogens. 2025. PMID: 40333162 Free PMC article.
-
A shift in the hepatitis C virus genotype dominance in blood donor samples from Thailand.Mol Biol Rep. 2011 Oct;38(7):4287-90. doi: 10.1007/s11033-010-0552-x. Epub 2010 Nov 27. Mol Biol Rep. 2011. PMID: 21113670
-
Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era.PLoS One. 2016 Sep 15;11(9):e0163095. doi: 10.1371/journal.pone.0163095. eCollection 2016. PLoS One. 2016. PMID: 27631382 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical